Hydantoin

Hydantoin

SCHEMBL3246334

I.O=C1CNC(=O)N1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Hydantoin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydantoin SCHEMBL7285865 0.97 — —
Hydantoin SCHEMBL27705088 0.97 CRBN (0.52) —
Hydantoin SCHEMBL27690 0.97 — —
Hydantoin SCHEMBL10770473 0.94 — —
Hydantoin SCHEMBL1786052 0.94 — —
Hydantoin SCHEMBL3479397 0.94 — —
Hydantoin SCHEMBL2224461 0.94 — —
Hydantoin SCHEMBL21352289 0.94 — —
Hydantoin SCHEMBL22371823 0.94 — —
Hydantoin SCHEMBL10578141 0.94 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2341777-B1 ANTIMICROBIAL OXAZOLIDINONE, HYDANTOIN AND IMIDAZOLIDINONE COMPOSITIONS NOVABAY PHARMACEUTICALS INC (US) 2015-01-21 — — EP disclosed
US-8722715-B2 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions NovaBay Pharmaceuticals (US) 2014-05-13 — — US disclosed
US-20100137349-A1 ANTIMICROBIAL OXAZOLIDINONE, HYDANTOIN AND IMIDAZOLIDINONE COMPOSITIONS NOVABAY PHARMACEUTICALS, INC. 2010-06-03 — — US disclosed
WO-2010054009-A1 ANTIMICROBIAL OXAZOLIDINONE, HYDANTOIN AND IMIDAZOLIDINONE COMPOSITIONS NOVABAY PHARMACEUTICALS, INC. (US) 2010-05-14 — — WO disclosed
Send feedback